Navigation Links
OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Date:3/25/2013

SAN DIEGO, March 25, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCQB: ONCS) – a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors – announced positive, durable response results in an update on interim data from its Phase II metastatic melanoma trial. The data was presented at the HemOnc Today Melanoma and Cutaneous Malignancies Conference on March 22, in New York City.

(Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)

In this analysis, all melanoma lesions that demonstrated at least a partial or complete response (PR or CR) to treatment with ImmunoPulse were followed, to determine durable response. Sixty-eight percent and forty-five percent of treated lesions demonstrated a durable response at three and six months, respectively.

Punit Dhillon , President and CEO said, "We are encouraged by this updated data from the interim analysis, especially in light of recent announcements related to durability of response for other intralesional therapies. This data not only shows that ImmunoPulse can effectively eliminate the targeted tumors but also that our treatment can have a lasting effect on those tumors."

Adil Daud , MD – the study's principal investigator at the University of California San Francisco – said, "This data demonstrates that the lesions we have selected for treatment are responding well to the therapy and that the ImmunoPulse can trigger a lasting immune response, against the treated lesion. It is now important for us to see if this local immune reaction can result in a more widespread response against untreated lesions."

These interim results reinforce previously announced Phase I data demonstrating that ImmunoPulse therapy is safe
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Johnson & Johnson (NYSE: ... at 10 a.m. (Eastern Time) on Thursday, April 23, 2015, ... Investors and other interested parties may ... the Company,s website at www.jnj.com and clicking on ... the meeting will be made available a few hours after ...
(Date:3/27/2015)... March 27, 2015  WebMD Health Corp. ... of health information, today announced an exclusive ... National Action Plan for Combating Antibiotic-Resistant Bacteria ... the urgency and importance of addressing antibiotic-resistant ... global health.    The WebMD interview, ...
(Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... results for the third quarter of 2011 after closing of the ... conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and ... the same day at 5:00pm ET (2:00pm PT) and will be ...
... STAAR Surgical Company (NASDAQ: STAA ) ... the third quarter ended September 30, 2011. The Company ... final results on Monday, October 24, 2011 in order ... other attendees of the American Association of Ophthalmology (AAO) ...
Cached Medicine Technology:Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 3STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 4STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 5
(Date:3/27/2015)... 2015 Approximately 300 advocates participated ... Coalition Lobby Day to lobby for physical education, ... (SHIP). Everlast Climbing was especially interested in ... which would strengthen physical education programs by adopting ... other measures to strengthen physical education in schools. ...
(Date:3/27/2015)... New Jersey (PRWEB) March 27, 2015 ... singer-songwriter-actress has released the official music video for her ... label. , Combining live-action and abstract styling effects, ... can be viewed on YouTube, Vimeo, and assorted outlets. ... in the development of an expanding full-scale marketing strategy. ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of the end of ... war and the amazing President that led our country through ... Civil War and Abraham Lincoln. This moving event will be ... Pickens Theater in Newport, RI. , Chief Justice (Ret.) ... master of ceremonies. Dr. Fred Zilian, educator, writer and actor, ...
(Date:3/27/2015)... DC (PRWEB) March 27, 2015 The ... with Accelerate Brain Cancer Cure (ABC2), awarded $350,000 to ... University of Florida, The Scripps Research Institute and H. ... awards support studies with a clear development path and ... patients in the near future. , The awards ...
(Date:3/26/2015)... March 27, 2015 Moreno Ranches, a ... announce prestigious victories at the 2015 International Brahman Show ... quite successful across many categories of show cattle for ... at the ABBA International Brahman show,” explained Kelvin Moreno, ... and the proof of our superior genetics is in ...
Breaking Medicine News(10 mins):Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2
... 2008 Studies published in a special issue of the ... by the University of California Press reveal that abstinence-only-until-marriage ... teenagers, provide inaccurate information about condoms, and violate human ... professor and chair of the Heilbrunn Department of Family ...
... had a twenty-five percent increase in the number of air ambulance ... ... Scottsdale, AZ (PRWEB) September 16, 2008 -- Angel MedFlight ... increase in the number of air ambulance flights they operated in ...
... OAK BROOK, Ill. Canadian researchers have used three-dimensional magnetic ... walls of diseased carotid arteries, a condition that may lead ... the October issue of Radiology suggest the technique ... at high risk for stroke. , When major arteries ...
... Not yet. But a new study offers new evidence ... help. The three-year study showed that trial participants who ... a "Jackson" cold or flu. The very sensitive Jackson ... clinical symptoms, which include coughing, sneezing, runny noses and ...
... Not only restores aesthetics, but also improves speech recognition ... can help improve hearing and speech recognition for people ... cancer surgery, a new U.S. study reports. , In ... lost, the external auditory canal is usually intact, and ...
... Scientists and clinicians from around the world will ... American Association for Cancer Research,s third International Conference ... The conference is subtitled, "Fulfilling the Promise of ... diagnostics to provide new strategies for tailoring therapies ...
Cached Medicine News:Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 2Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 3Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 4Health News:Substantial Second Quarter Surge for Angel MedFlight Worldwide Air Ambulance Services 2Health News:3-D MRI technique helps radiologists detect high-risk carotid disease 2Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 2Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 3Health News:Prosthetic Ears Boost Hearing After Injury 2Health News:Scientists take cancer research back to the basic molecular level 2
... determination of Estradiol (E2) concentration in human serum ... hormone with a phenolic A ring. This ... It is the most potent natural Estrogen, ... smaller amounts by the adrenal cortex, and the ...
... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
Clinical marker immunoassay kit for detection of Myoglobin....
Medicine Products: